Shenzhen Key Laboratory of Ophthalmology, Shenzhen Eye Hospital, School of Optometry, Shenzhen University, Shenzhen, China.
Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4937-4944. doi: 10.1167/iovs.18-24978.
We evaluated the effects of lentivirus-mediated exoenzyme C3 transferase (C3) expression on cultured primary human trabecular meshwork (HTM) cells in vitro, and on rat intraocular pressure (IOP).
HTM cells were cultured and treated with lentivirus vectors expressing either green fluorescent protein (GFP) only (LV-GFP) or GFP and C3 together (LV-C3-GFP). Changes in cell morphology and actin stress fibers were assessed. The vectors were also injected into the anterior chamber of rats, and GFP expression was visualized by a Micron III Retinal Imaging Microscope in vivo and a fluorescence microscope ex vivo. Changes in rat IOP were monitored by using a rebound tonometer and the eyes were evaluated by slit lamp.
LV-mediated C3 expression induced morphologic changes in HTM cells. The cells became retracted and rounded. GFP expression in the anterior chamber angle of rats was observed in vivo from 8 days to 48 days after injection of LV-C3-GFP or LV-GFP. IOP was significantly decreased in the LV-C3-GFP group starting 3 days post injection, and lasting for at least 40 days, when compared to either the contralateral control eyes (the LV-GFP group) or the ipsilateral baseline before injection (P < 0.05). No obvious inflammatory signs were observed in either the LV-C3-GFP or LV-GFP groups.
LV-mediated C3 expression induced changes in morphology of cultured HTM cells. Intracameral injection of LV-C3-GFP lowered rat IOP for at least 40 days. No significant inflammatory reactions were observed in either the LV-C3-GFP or LV-GFP groups. This study supports the possible use of C3 gene therapy for the treatment of glaucoma.
我们评估了慢病毒介导的外酶 C3 转移酶(C3)表达对体外培养的原代人眼小梁网(HTM)细胞和大鼠眼内压(IOP)的影响。
培养 HTM 细胞并使用表达绿色荧光蛋白(GFP)的慢病毒载体(LV-GFP)或同时表达 GFP 和 C3 的慢病毒载体(LV-C3-GFP)处理。评估细胞形态和肌动蛋白应力纤维的变化。将载体注入大鼠前房,通过体内 Micron III 视网膜成像显微镜和体外荧光显微镜观察 GFP 表达。通过回弹眼压计监测大鼠 IOP 的变化,并通过裂隙灯评估眼睛。
LV 介导的 C3 表达诱导 HTM 细胞形态发生变化。细胞回缩并变圆。LV-C3-GFP 或 LV-GFP 注射后 8 天至 48 天,在大鼠前房角可在体内观察到 GFP 表达。与对侧对照眼(LV-GFP 组)或注射前同侧基线相比,LV-C3-GFP 组大鼠 IOP 从注射后 3 天开始显著降低,至少持续 40 天(P <0.05)。在 LV-C3-GFP 或 LV-GFP 组均未观察到明显的炎症迹象。
LV 介导的 C3 表达诱导培养的 HTM 细胞形态发生变化。LV-C3-GFP 眼内注射可使大鼠 IOP 降低至少 40 天。在 LV-C3-GFP 或 LV-GFP 组均未观察到明显的炎症反应。这项研究支持 C3 基因治疗治疗青光眼的可能性。